Gilles Vassal
- Genetics top 0.5%
- Glioma Diagnosis and Treatment 60
- Neurology top 0.5%
- Neuroblastoma Research and Treatments 87
- Cancer Research top 1%
- Cancer Genomics and Diagnostics 31
- Cancer, Hypoxia, and Metabolism 29
- Oncology top 0.5%
- Hematology top 1%
-
- Cancer therapeutics and mechanisms 52
-
- Childhood Cancer Survivors' Quality of Life 51
- Pharmaceutical studies and practices 33
-
- Lung Cancer Treatments and Mutations 32
- Co-authors
- Birgit GeoergerJ LemerleAlain GouyetteJackie MorizetAlain DeroussentOlivier HartmannDominique Valteau‐CouanetC Kalifa
- Cited by
- GeneticsNeurologyCancer Research
- Journals
- Journal of Clinical Oncology (43 papers)European Journal of Cancer (38 papers)British Journal of Cancer (13 papers)
- Partner nations
- FranceUnited KingdomUnited States
In The Last Decade
Gilles Vassal
319 papers receiving 9.4k citations
Peers
Comparison fields: 5 of 150
- Genetics 1.8k
- Neurology 2.0k
- Cancer Research 1.6k
- Oncology 2.7k
- Hematology 1.1k
Countries citing papers authored by Gilles Vassal
This map shows the geographic impact of Gilles Vassal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gilles Vassal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gilles Vassal more than expected).
Fields of papers citing papers by Gilles Vassal
This network shows the impact of papers produced by Gilles Vassal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gilles Vassal. The network helps show where Gilles Vassal may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Gilles Vassal, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 1 | |
| 3 | 2023 | 0 | |
| 4 | 2022 | 9 | |
| 5 | 2022 | 10 | |
| 6 | 2022 | 6 | |
| 7 | 2022 | 12 | |
| 8 | 2021 | 16 | |
| 9 | 2021 | 36 | |
| 10 | 2019 | 3 | |
| 11 | 2012 | 37 | |
| 12 | 2010 | 62 | |
| 13 | 2009 | 71 | |
| 14 | 2009 | 92 | |
| 15 | 2009 | 248 | |
| 16 | Acquired resistance to HSP90 inhibitor 17-allylamino-17-demethoxygeldanamycin (17-AAG) in adult and pediatric glioblastoma cell lines | 2008 | 1 |
| 17 | Squalenoylation a new concept in drug targeting: evidence of a potent anti-cancer activity of squalenoyl-gemcitabine | 2008 | 1 |
| 18 | Les essais cliniques en cancérologie pédiatrique - Recommandations pour le développement des nouveaux agents anticancéreux | 2003 | 1 |
| 19 | Tumeurs cérébrales de l’enfant | 1998 | 2 |
| 20 | Busulfan metabolism in cytosolic and microsomal mouse liver preparations | 1993 | 1 |
About Gilles Vassal
Gilles Vassal is a scholar working on Genetics, Neurology and Cancer Research, having authored 329 papers that have together received 9.6k indexed citations. Recurring topics across this work include Neuroblastoma Research and Treatments (87 papers), Glioma Diagnosis and Treatment (60 papers), Cancer therapeutics and mechanisms (52 papers), Childhood Cancer Survivors' Quality of Life (51 papers), Pharmaceutical studies and practices (33 papers), Lung Cancer Treatments and Mutations (32 papers), Cancer Genomics and Diagnostics (31 papers) and Cancer, Hypoxia, and Metabolism (29 papers). The work is most often cited by research in Genetics (1.8k citations), Neurology (2.0k citations) and Cancer Research (1.6k citations). Gilles Vassal has collaborated with scholars based in France, United Kingdom and United States. Frequent co-authors include Birgit Geoerger, J Lemerle, Alain Gouyette, Jackie Morizet, Alain Deroussent, Olivier Hartmann, Dominique Valteau‐Couanet, C Kalifa, Angélo Paci and Paule Opolon. Their work appears in journals such as Journal of Clinical Oncology, European Journal of Cancer, British Journal of Cancer, Cancer Research and The Lancet Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.